| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.750 | 23.938 | 23.524 | 26.309 | 28.000 | 31.815 | 32.893 | 35.187 | 38.501 | 43.718 |
| Total Income - EUR | 22.750 | 23.938 | 23.533 | 26.309 | 28.000 | 31.815 | 32.893 | 35.187 | 38.501 | 43.718 |
| Total Expenses - EUR | 21.939 | 23.644 | 24.121 | 24.907 | 25.010 | 24.519 | 22.607 | 25.145 | 30.117 | 33.506 |
| Gross Profit/Loss - EUR | 811 | 294 | -588 | 1.402 | 2.990 | 7.295 | 10.286 | 10.043 | 8.384 | 10.212 |
| Net Profit/Loss - EUR | 128 | 103 | -824 | 1.138 | 2.710 | 7.082 | 9.957 | 9.691 | 7.999 | 8.901 |
| Employees | 0 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Carmadiamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 249 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 645 | 659 |
| Current Assets | 2.552 | 2.284 | 3.616 | 2.016 | 4.902 | 8.815 | 8.763 | 9.228 | 9.309 | 11.341 |
| Inventories | 585 | 294 | 452 | 610 | 200 | 0 | 0 | 78 | 73 | 0 |
| Receivables | 446 | 957 | 728 | 858 | 751 | 145 | 217 | 1.585 | 1.567 | 0 |
| Cash | 1.521 | 1.033 | 2.436 | 548 | 3.951 | 8.670 | 8.546 | 7.566 | 7.669 | 11.341 |
| Shareholders Funds | 390 | 489 | -343 | 802 | 3.496 | 10.512 | 9.997 | 9.731 | 8.039 | 8.941 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.411 | 1.795 | 3.959 | 1.216 | 1.406 | 1.522 | 1.891 | 1.618 | 1.915 | 3.060 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Carmadiamed Srl